市场调查报告书
商品编码
1390591
2023-2028 年按疾病类型、测试类型、服务和地区分類的家禽诊断市场报告Poultry Diagnostics Market Report by Disease Type, Test Type, Service, and Region 2023-2028 |
2022年,全球家禽诊断市场规模达到4.418亿美元。展望未来, IMARC Group预计到2028年市场规模将达到7.912亿美元,2022-2028年复合年增长率(CAGR)为10.20%。家禽消费量的增加、禽流感和新城疫的频繁爆发、严格的食品安全法规、重大的技术进步、对家禽疫情相关经济损失的认识不断提高以及该领域持续的研究和开发活动是推动这一领域发展的一些关键因素。市场。
家禽诊断是家禽业的一个重要方面,重点是识别和管理家禽群中的疾病和健康问题。它在确保家禽的健康方面发挥关键作用,反过来又保障了消费者家禽产品的品质。这些诊断涵盖一系列技术,包括实验室测试、临床检查和先进的影像技术。家禽诊断的主要目标是及时发现和解决疾病,例如禽流感、新城疫和球虫病等。早期检测对于防止疾病在鸡群内传播、减少经济损失和维持食品安全标准至关重要。此外,它有助于制定有效的疫苗接种和治疗策略。
全球对家禽产品的需求不断增长,作为负担得起的瘦肉蛋白质来源,这是一个主要驱动力。消费量的激增需要强有力的诊断,以确保家禽群的健康和安全。此外,禽流感、新城疫等疾病的频繁爆发,也凸显了家禽生产的脆弱性。这导致对诊断工具的更多投资,以快速识别和控制疾病。除此之外,家禽生产者越来越意识到与疾病爆发相关的经济损失。这种意识促使他们投资于主动诊断措施,以保护他们的羊群和利润。除此之外,世界各国政府正在对食品安全(包括家禽产品)执行更严格的法规。家禽诊断对于遵守这些法规和维持消费者信任至关重要。与此一致的是,PCR和ELISA等诊断技术的进步提高了疾病检测的速度和准确性。这刺激了这些诊断方法在家禽业的采用。此外,家禽诊断领域正在进行的研究正在导致更复杂、更有效的诊断工具的开发,吸引投资和市场成长。
家禽消费量上升
鸡和火鸡等家禽是全球不断增长的人口负担得起的优质蛋白质的重要来源。随着越来越多的人将家禽纳入饮食中,越来越需要确保家禽群的健康和安全以满足这一需求。家禽诊断在维持这些家禽的健康方面发挥关键作用,这直接影响可供消费的家禽产品的品质和数量。健康的鸡群生产力更高,不易爆发疾病,有助于提高家禽养殖业的整体效率。因此,家禽消费的成长与保护动物健康和食品安全的有效诊断需求有着内在的关联。
疾病频繁爆发
这些疾病可以在鸡群中迅速传播,对家禽生产者造成重大经济损失。为此,家禽业已经认识到疾病的早期发现和管理的至关重要性。家禽诊断是快速识别导致这些疫情的病原体的存在不可或缺的工具。快速诊断可以及时实施检疫和疫苗接种等控制措施,以遏制疾病传播并限制经济损失。疾病爆发可能导致家禽生产大规模中断,这使得家禽诊断成为该行业可持续发展的基本投资。
严格的食品安全法规
各国政府和监管机构越来越重视确保消费者家禽产品的安全。这包括监测和控制可从家禽传播给人类的疾病。家禽诊断在满足这些监管要求方面发挥关键作用。它们使家禽生产商能够证明其遵守严格的健康和安全标准,确保家禽产品不含致病因子。不遵守这些规定可能会导致产品召回、法律后果以及公司声誉受损。
IMARC Group提供了对市场报告各细分市场主要趋势的分析,以及 2023 年至 2028 年全球、区域和国家层面的预测。我们的报告根据疾病类型、测试类型和服务对市场进行了分类。
禽流感
禽沙门氏菌病
禽支原体疾病
传染性支气管炎
传染性法氏囊病
新城疫
鸡贫血症
其他的
禽流感占大部分市场份额
该报告根据疾病类型对市场进行了详细的细分和分析。这包括禽流感、禽沙门氏菌病、禽支原体病、传染性支气管炎、新城疫、鸡贫血等。根据该报告,禽流感占最大部分。
禽流感,俗称禽流感,由于其高度传染性和在家禽群内快速传播的潜力,对全球家禽业构成重大威胁。这种增加的风险促使家禽生产者优先考虑禽流感诊断,作为保护其鸡群的主动措施。此外,禽流感因其人畜共患的潜力(这意味着它可以从鸟类传播给人类)而引起了各国政府和国际组织的广泛关注。这种对动物和人类健康的双重威胁导致了严格的监测和控制措施,进一步推动了对禽流感诊断的需求,以确保早期发现和遏制。此外,禽流感的爆发可能导致毁灭性的经济损失,包括大规模扑杀受感染的鸟类、贸易限制以及消费者对家禽产品的信心下降。因此,禽流感爆发的经济影响促使家禽生产商大力投资禽流感诊断,作为其风险缓解策略的一部分。
酵素连结免疫吸附试验
PCR检测
其他的
ELISA检测产业占有率第一
报告中还提供了基于测试类型的详细市场区隔和分析。这包括 ELISA 测试、PCR 测试等。报告显示,ELISA检测占据最大的市场份额。
ELISA 以其在检测多种家禽疾病(包括禽流感、新城疫和沙门氏菌病等)方面的多功能性和广泛适用性而闻名。这种多功能性使其成为许多家禽生产商和诊断实验室作为综合诊断工具的首选。除此之外,ELISA 测试具有高灵敏度和特异性,确保结果准确可靠。家禽业非常重视精确的疾病检测,以便及时做出明智的决策,例如启动疾病控制措施或治疗方案。此外,与其他一些诊断方法相比,ELISA 测试相对具有成本效益,这使其成为家禽生产商寻求有效疾病管理而不显着增加营运成本的有吸引力的选择。此外,ELISA 技术的成熟性质以及大量经过验证的检测方法,使行业专业人士和监管机构对其有效性充满信心。对 ELISA 可靠性的信心及其成功疾病管理的记录有助于其成为按测试类型分類的市场中最大的细分市场。
细菌学
寄生虫学
病毒学
细菌学代表了领先的细分市场
该报告根据服务提供了详细的市场细分和分析。这包括细菌学、寄生虫学和病毒学。根据该报告,细菌学占最大的部分。
细菌在家禽健康中发挥关键作用,因为细菌感染可以在鸡群中迅速传播并导致严重的经济损失。细菌学服务包括分离、鑑定和表征导致各种家禽疾病的细菌病原体。这包括沙门氏菌和大肠桿菌感染等常见问题,这些问题对家禽健康和食品安全都有重大影响。此外,食品安全法规和消费者对安全家禽产品的需求加剧了对家禽细菌病原体的关注。因此,家禽生产商和加工商严重依赖细菌学服务来确保其产品符合严格的安全标准并且不会对消费者构成健康风险。此外,细菌学的不断研究和创新促进了先进诊断技术的发展,例如DNA定序和分子方法,这些技术提供了更高的特异性和灵敏度。这进一步巩固了细菌学作为家禽诊断市场最大服务领域的地位,满足了动物健康和公共卫生的关键需求。
北美洲
美国
加拿大
亚太
中国
日本
印度
韩国
澳洲
印尼
其他的
欧洲
德国
法国
英国
义大利
西班牙
俄罗斯
其他的
拉丁美洲
巴西
墨西哥
其他的
中东和非洲
北美市场领先,占据最大的家禽诊断市场份额
市场研究报告还对所有主要区域市场进行了全面分析,其中包括北美(美国和加拿大);欧洲(德国、法国、英国、义大利、西班牙、俄罗斯等);亚太地区(中国、日本、印度、韩国、澳洲、印尼等);拉丁美洲(巴西、墨西哥等);以及中东和非洲。报告称,北美占据最大的市场份额。
北美拥有完善且高度工业化的家禽业,美国是全球最大的家禽生产国之一。大量的家禽生产需要严格的疾病管理,以确保家禽群的健康和安全以及家禽产品的品质,从而产生了对诊断服务和工具的大量需求。此外,该地区非常重视食品安全和消费者健康。严格的监管框架和消费者对安全家禽产品的期望刺激了对先进诊断技术的投资,以有效检测和管理疾病,从而支持家禽诊断市场的成长。除此之外,北美受益于成熟的医疗保健和兽医基础设施,促进了尖端诊断方法的采用。领先的诊断公司、研究机构和兽医诊所的存在进一步促进了该地区家禽诊断的可用性和利用。此外,北美对家禽业研发的积极态度确保了诊断技术的持续创新,并满足该行业不断变化的需求。
家禽诊断领域的领先公司正在大力投资研发。他们正在开发创新的诊断工具和技术,以提高疾病检测的敏感度、特异性和速度。这种对创新的承诺确保家禽生产者能够获得最先进的诊断技术来保护他们的鸡群。此外,许多主要参与者正在与研究机构和兽医组织建立策略合作伙伴关係。这些合作促进了知识交流,从而发展了尖端的诊断解决方案。合作伙伴关係还有助于扩大市场范围并确保先进诊断技术的广泛采用。除此之外,认识到家禽业的全球性,主要参与者正在扩大在各个地区的业务。这包括建立分销网络、建立子公司以及进入具有高家禽生产潜力的新兴市场。透过在全球范围内提供诊断产品和服务,这些公司正在利用家禽诊断不断增长的需求。此外,根据家禽生产者的具体需求客製化诊断解决方案是一项值得注意的策略。主要参与者正在提供客製化的诊断包,以解决不同家禽养殖场面临的独特挑战。这种方法可以提高客户满意度并促进长期合作伙伴关係。
农业生物泰克实验室
生物化学公司
百奥诺特有限公司
勃林格殷格翰国际股份有限公司
IDEXX 实验室公司
MEGACOR 诊断有限公司
凯杰公司
Gezondheidsdienst voor Dieren BV(皇家 GD)
赛默飞世尔科技公司
硕腾公司
(请注意,这只是关键参与者的部分列表,报告中提供了完整列表。)
2022 年,IDEXX Laboratories Inc 宣布推出一系列新的诊断测试以及新的软体应用程序,以帮助农民和生产者管理家禽健康。它还引入了快速检测方法和诊断分析,为家禽疾病提供快速、准确的结果。
Qiagen 是家禽诊断市场的领导者,致力于为家禽产业开发分子诊断解决方案。它推出了先进的基于 DNA 和 RNA 的测试来检测家禽中的各种病原体和疾病。
Thermo Fisher Scientific Inc 一直积极参与家禽诊断市场。它开发了创新的解决方案,例如基于 PCR 的检测试剂盒和先进的诊断仪器,以准确检测家禽疾病。
The global poultry diagnostics market size reached US$ 441.8 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 791.2 Million by 2028, exhibiting a growth rate (CAGR) of 10.20% during 2022-2028. The rising poultry consumption, frequent outbreaks of avian influenza and Newcastle disease, stringent food safety regulations, significant technological advancements, growing awareness about the economic losses associated with poultry outbreaks, and ongoing research and development activities in this field are some of the key factors driving the market.
Poultry diagnostics is a crucial aspect of the poultry industry, focusing on the identification and management of diseases and health issues in poultry flocks. It plays a pivotal role in ensuring the well-being of poultry birds, which, in turn, safeguards the quality of poultry products for consumers. These diagnostics encompass a range of techniques, including laboratory tests, clinical examinations, and advanced imaging technologies. The primary objective of poultry diagnostics is to promptly detect and address diseases, such as avian influenza, Newcastle disease, and coccidiosis, among others. Early detection is vital to prevent the spread of diseases within flocks, reduce economic losses, and maintain food safety standards. Moreover, it aids in the development of effective vaccination and treatment strategies.
The increasing global demand for poultry products as a source of affordable and lean protein is a primary driver. This surge in consumption necessitates robust diagnostics to ensure the health and safety of poultry flocks. Additionally, frequent outbreaks of diseases like avian influenza and Newcastle disease have highlighted the vulnerability of poultry production. This has led to greater investments in diagnostic tools to quickly identify and contain diseases. Other than this, poultry producers are becoming increasingly aware about the economic losses associated with disease outbreaks. This awareness drives them to invest in proactive diagnostic measures to protect their flocks and bottom lines. Besides this, governments worldwide are enforcing stricter regulations on food safety, including poultry products. Poultry diagnostics are essential for compliance with these regulations and to maintain consumer trust. In line with this, advances in diagnostic technologies, such as PCR and ELISA, have enhanced the speed and accuracy of disease detection. This has spurred the adoption of these diagnostic methods in the poultry industry. Furthermore, ongoing research in the field of poultry diagnostics is leading to the development of more sophisticated and effective diagnostic tools, attracting both investments and market growth.
Rising Poultry Consumption
Poultry, such as chickens and turkeys, is a significant source of affordable and high-quality protein for a growing global population. As more people include poultry in their diets, there is a greater need to ensure the health and safety of poultry flocks to meet this demand. Poultry diagnostics play a critical role in maintaining the health of these birds, which directly impacts the quality and quantity of poultry products available for consumption. Healthy flocks are more productive and less prone to disease outbreaks, contributing to the overall efficiency of poultry farming operations. Therefore, the rise in poultry consumption is intrinsically linked to the demand for effective diagnostics to safeguard both animal health and food safety.
Frequent Disease Outbreaks
These diseases can spread rapidly within flocks, leading to significant economic losses for poultry producers. In response, the poultry industry has recognized the critical importance of early detection and management of diseases. Poultry diagnostics are indispensable tools for swiftly identifying the presence of pathogens responsible for these outbreaks. Rapid diagnosis allows for timely implementation of control measures, such as quarantine and vaccination, to contain the spread of the disease and limit economic losses. The potential for large-scale disruptions in poultry production due to disease outbreaks has made poultry diagnostics a fundamental investment for the sustainability of the industry.
Stringent Food Safety Regulations
Governments and regulatory bodies are placing greater emphasis on ensuring the safety of poultry products for consumers. This includes monitoring and controlling diseases that can be transmitted from poultry to humans. Poultry diagnostics play a pivotal role in meeting these regulatory requirements. They enable poultry producers to demonstrate compliance with strict health and safety standards, ensuring that poultry products are free from disease-causing agents. Failure to adhere to these regulations can result in product recalls, legal consequences, and damage to a reputation of a company.
IMARC Group provides an analysis of the key trends in each segment of the market report, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on disease type, test type, and service.
Avian Influenza
Avian Salmonellosis
Avian Mycoplasmosis
Infectious Bronchitis
Infectious Bursal Disease
Newcastle Disease
Chicken Anemia
Others
Avian Influenza accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the disease type. This includes avian influenza, avian salmonellosis, avian mycoplasmosis, infectious bronchitis, Newcastle disease, chicken anemia, and others. According to the report, Avian Influenza represented the largest segment.
Avian influenza, commonly known as bird flu, poses a significant threat to the global poultry industry due to its highly contagious nature and potential for rapid transmission within poultry flocks. This heightened risk has prompted poultry producers to prioritize avian influenza diagnostics as a proactive measure to protect their flocks. Additionally, avian influenza has garnered substantial attention from governments and international organizations due to its zoonotic potential, meaning it can be transmitted from birds to humans. This dual threat to animal and human health has led to stringent monitoring and control measures, further driving the demand for avian influenza diagnostics to ensure early detection and containment. Moreover, avian influenza outbreaks can result in devastating economic losses, including mass culling of infected birds, trade restrictions, and decreased consumer confidence in poultry products. Therefore, the economic implications of avian influenza outbreaks have incentivized poultry producers to invest significantly in avian influenza diagnostics as part of their risk mitigation strategies.
ELISA test
PCR Test
Others
ELISA test holds the largest share in the industry
A detailed breakup and analysis of the market based on the test type has also been provided in the report. This includes ELISA test, PCR test, and others. According to the report, ELISA test accounted for the largest market share.
ELISA is renowned for its versatility and wide applicability in detecting a broad spectrum of poultry diseases, including avian influenza, Newcastle disease, and salmonellosis, among others. This versatility makes it a preferred choice for many poultry producers and diagnostic laboratories as a comprehensive diagnostic tool. Besides this, ELISA tests offer high sensitivity and specificity, ensuring accurate and reliable results. The poultry industry places a premium on precise disease detection to make informed decisions promptly, such as initiating disease control measures or treatment protocols. Furthermore, ELISA tests are relatively cost-effective when compared to some other diagnostic methods, making them an attractive option for poultry producers seeking efficient disease management without significantly increasing operational costs. Additionally, the well-established nature of ELISA technology, along with a wealth of validated assays, instills confidence in its effectiveness among industry professionals and regulatory bodies. This confidence in reliability of ELISA and its track record of successful disease management contributes to its status as the largest segment in the market by test type.
Bacteriology
Parasitology
Virology
Bacteriology represents the leading market segment
The report has provided a detailed breakup and analysis of the market based on the service. This includes bacteriology, parasitology, and virology. According to the report, bacteriology represented the largest segment.
Bacteria play a pivotal role in poultry health, as bacterial infections can quickly spread within flocks and lead to severe economic losses. Bacteriology services encompass the isolation, identification, and characterization of bacterial pathogens responsible for various poultry diseases. This includes common issues like Salmonella and E. coli infections, which have significant implications for both poultry health and food safety. Moreover, food safety regulations and consumer demand for safe poultry products have intensified the focus on bacterial pathogens in poultry. As a result, poultry producers and processors rely heavily on bacteriology services to ensure that their products meet stringent safety standards and do not pose health risks to consumers. Furthermore, continuous research and innovation in bacteriology have led to the development of advanced diagnostic techniques, such as DNA sequencing and molecular methods, which offer higher specificity and sensitivity. This has further solidified position of bacteriology as the largest segment in the poultry diagnostics market by service, addressing critical needs for both animal health and public health.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America leads the market, accounting for the largest poultry diagnostics market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America has a well-established and highly industrialized poultry sector, with the United States being one of the largest poultry producers globally. This substantial poultry production requires rigorous disease management to ensure the health and safety of poultry flocks and the quality of poultry products, creating a substantial demand for diagnostic services and tools. Additionally, the region places a strong emphasis on food safety and consumer health. Stringent regulatory frameworks and consumer expectations for safe poultry products have spurred investments in advanced diagnostic technologies to detect and manage diseases effectively, thus supporting the growth of the poultry diagnostics market. Other than this, North America benefits from a mature healthcare and veterinary infrastructure, fostering the adoption of cutting-edge diagnostic methods. The presence of leading diagnostic companies, research institutions, and veterinary clinics further contributes to the availability and utilization of poultry diagnostics in the region. Furthermore, the proactive approach of North America to research and development in the poultry industry ensures a continuous flow of innovation in diagnostics, meeting the evolving needs of the sector.
Leading companies in the poultry diagnostics sector are heavily investing in R&D. They are developing innovative diagnostic tools and technologies that offer higher sensitivity, specificity, and speed in disease detection. This commitment to innovation ensures that poultry producers have access to state-of-the-art diagnostics to safeguard their flocks. Additionally, numerous key players are forming strategic partnerships with research institutions and veterinary organizations. These collaborations foster knowledge exchange, allowing for the development of cutting-edge diagnostic solutions. Partnerships also help in expanding market reach and ensuring the widespread adoption of advanced diagnostic technologies. Other than this, recognizing the global nature of the poultry industry, key players are expanding their presence in various regions. This involves setting up distribution networks, establishing subsidiaries, and entering emerging markets with high poultry production potential. By offering their diagnostic products and services worldwide, these companies are capitalizing on the growing demand for poultry diagnostics. Furthermore, tailoring diagnostic solutions to the specific needs of poultry producers is a notable strategy. Key players are offering customized diagnostic packages that address the unique challenges faced by different poultry operations. This approach enhances customer satisfaction and fosters long-term partnerships.
AgroBioTek Laboratories
BioChek B.V.
Bionote Co. Ltd.
Boehringer Ingelheim International GmbH
IDEXX Laboratories Inc.
MEGACOR Diagnostik GmbH
QIAGEN N.V.
Gezondheidsdienst voor Dieren B.V. (Royal GD)
Thermo Fisher Scientific Inc.
Zoetis Inc.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
In 2022, IDEXX Laboratories Inc has announced the launch of a number of new diagnostic tests, as well as a new software application that helps farmers and producers to manage their poultry health. It has also introduced rapid testing methods and diagnostic assays that provide quick and accurate results for poultry diseases.
Qiagen, a leading player in the poultry diagnostics market, has focused on developing molecular diagnostic solutions for the poultry industry. It has launched advanced DNA and RNA-based tests to detect various pathogens and diseases in poultry.
Thermo Fisher Scientific Inc has been actively involved in the poultry diagnostics market. It has developed innovative solutions such as PCR-based testing kits and advanced diagnostic instruments to detect poultry diseases accurately.